Literature DB >> 6284646

Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus-infected cell extracts by human sera.

L Pereira, M Hoffman, N Cremer.   

Abstract

Serodiagnosis of cytomegalovirus (CMV) infection by complement fixation tests depends on showing a fourfold rise in antibody titer from acute- to convalescent-phase sera. Freeze-thaw and glycine-extracted, infected cell culture antigens used for these tests give markedly different titers in reactions with the same sera. In this study, we characterized the CMV-infected cell polypeptides contained in freeze-thaw and glycine-extracted antigens and identified the proteins precipitated by 23 pairs of human acute and convalescent sera. Our results were as follows. First, freeze-thaw and glycine-extracted antigens prepared from infected cells radiolabeled with [35S]methionine and subjected to electrophoresis in sodium dodecyl sulfate-polyacrylamide gels yielded similar patterns, and the bulk of the label was contained in late structural proteins and glycoproteins. Glycine-extracted preparations contained a greater proportion of soluble 66,000- and 50,000-molecular-weight proteins than did freeze-thaw antigens. Second, convalescent sera precipitated proteins migrating with apparent molecular weights of 150,000, 130,000, 110,000, 96,000, 74,000, 66,000, 50,000, 34,000, 32,000, and 25,000. Of these the 130,000-, 110,000-, 96,000-, 66,000-, 50,000-, and 25,000-molecular-weight proteins comigrated with glucosamine-labeled polypeptides. Both immunoglobulin G and M antibodies in human sera precipitated these proteins from CMV-infected cell preparations. Implications of the results for serodiagnosis of CMV infections are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6284646      PMCID: PMC551420          DOI: 10.1128/iai.36.3.933-942.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  The morphogenesis of human cytomegalovirus. Isolation and polypeptide characterization of cytomegalovirions and dense bodies.

Authors:  I Sarov; I Abady
Journal:  Virology       Date:  1975-08       Impact factor: 3.616

2.  Complement-fixing antibody in human sera reactive with viral and soluble antigens of cytomegalovirus.

Authors:  N E Cremer; N J Schmidt; F Jensen; M Hoffman; L S Oshiro; E H Lennette
Journal:  J Clin Microbiol       Date:  1975-03       Impact factor: 5.948

3.  Partial characterization of a soluble antigen preparation from cells infected with human cytomegalovirus: properties of antisera prepared to the antigen.

Authors:  J L Waner
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

4.  Inapparent congenital cytomegalovirus infection with elevated cord IgM levels. Casual relation with auditory and mental deficiency.

Authors:  D W Reynolds; S Stagno; K G Stubbs; A J Dahle; M M Livingston; S S Saxon; C A Alford
Journal:  N Engl J Med       Date:  1974-02-07       Impact factor: 91.245

5.  Antibodies against membrane antigens of cytomegalovirus infected cells in sera of patients with a cytomegalovirus infection.

Authors:  T H The; M M Langenhuysen
Journal:  Clin Exp Immunol       Date:  1972-08       Impact factor: 4.330

6.  Patterns of cytomegaloviral complement-fixing antibody activity: a longitudinal study of blood donors.

Authors:  J L Waner; T H Weller; S V Kevy
Journal:  J Infect Dis       Date:  1973-05       Impact factor: 5.226

Review 7.  The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I.

Authors:  T H Weller
Journal:  N Engl J Med       Date:  1971-07-22       Impact factor: 91.245

8.  A serologic study of herpesvirus hominis strains by microneutralization tests.

Authors:  F P Pauls; W R Dowdle
Journal:  J Immunol       Date:  1967-05       Impact factor: 5.422

9.  Human cytomegalovirus: glycoproteins associated with virions and dense bodies.

Authors:  M F Stinski
Journal:  J Virol       Date:  1976-08       Impact factor: 5.103

10.  Cytomegalovirus proteins. I. Polypeptides of virions and dense bodies.

Authors:  M Fiala; R W Honess; D C Heiner; J W Heine; J Murnane; R Wallace; L B Guze
Journal:  J Virol       Date:  1976-07       Impact factor: 5.103

View more
  28 in total

1.  A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus.

Authors:  B Wagner; B Kropff; H Kalbacher; W Britt; V A Sundqvist; L Ostberg; M Mach
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

2.  Identification and characterization of three distinct families of glycoprotein complexes in the envelopes of human cytomegalovirus.

Authors:  D R Gretch; B Kari; L Rasmussen; R C Gehrz; M F Stinski
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Identification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cytomegalovirus UL82 (pp71) and UL83 (pp65) matrix phosphoproteins.

Authors:  L D Cranmer; C L Clark; C S Morello; H E Farrell; W D Rawlinson; D H Spector
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  Production and characterization of monoclonal antibodies specific for a glycosylated polypeptide of human cytomegalovirus.

Authors:  K S Kim; V J Sapienza; C M Chen; K Wisniewski
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

5.  Isolation and partial chemical characterization of a 64,000-dalton glycoprotein of human cytomegalovirus.

Authors:  B R Clark; J A Zaia; L Balce-Directo; Y P Ting
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

6.  Genome structure and virion polypeptides of the primate herpesviruses Herpesvirus aotus types 1 and 3: comparison with human cytomegalovirus.

Authors:  A Ebeling; G Keil; B Nowak; B Fleckenstein; N Berthelot; P Sheldrick
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

7.  Pattern of anti-cytomegalovirus IgM antibodies determined by immunoblotting. A study of kidney graft recipients developing a primary or recurrent CMV infection.

Authors:  J Basson; J C Tardy; M Aymard
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

8.  Human cytomegalovirus UL99-encoded pp28 is required for the cytoplasmic envelopment of tegument-associated capsids.

Authors:  Maria C Silva; Qian-Chun Yu; Lynn Enquist; Thomas Shenk
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Cloning and physical mapping of a gene fragment coding for a 64-kilodalton major late antigen of human cytomegalovirus.

Authors:  H Pande; S W Baak; A D Riggs; B R Clark; J E Shively; J A Zaia
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

10.  Cytomegalovirus-infected cell polypeptides immune-precipitated by sera from children with congenital and perinatal infections.

Authors:  L Pereira; S Stagno; M Hoffman; J E Volanakis
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.